Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. / Kallonen, Janica; Korsholm, Kasper; Bredin, Fredrik; Corbascio, Matthias; Jønsson Andersen, Mads; Ilkjær, Lars Bo; Mellemkjær, Søren; Sartipy, Ulrik.

I: Pulmonary Circulation, Bind 12, Nr. 2, e12093, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kallonen, J, Korsholm, K, Bredin, F, Corbascio, M, Jønsson Andersen, M, Ilkjær, LB, Mellemkjær, S & Sartipy, U 2022, 'Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension', Pulmonary Circulation, bind 12, nr. 2, e12093. https://doi.org/10.1002/pul2.12093

APA

Kallonen, J., Korsholm, K., Bredin, F., Corbascio, M., Jønsson Andersen, M., Ilkjær, L. B., Mellemkjær, S., & Sartipy, U. (2022). Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Pulmonary Circulation, 12(2), [e12093]. https://doi.org/10.1002/pul2.12093

Vancouver

Kallonen J, Korsholm K, Bredin F, Corbascio M, Jønsson Andersen M, Ilkjær LB o.a. Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 2022;12(2). e12093. https://doi.org/10.1002/pul2.12093

Author

Kallonen, Janica ; Korsholm, Kasper ; Bredin, Fredrik ; Corbascio, Matthias ; Jønsson Andersen, Mads ; Ilkjær, Lars Bo ; Mellemkjær, Søren ; Sartipy, Ulrik. / Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. I: Pulmonary Circulation. 2022 ; Bind 12, Nr. 2.

Bibtex

@article{421ccbe939994d1dbe336e9e845afcff,
title = "Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension",
abstract = "This study investigated whether residual pulmonary hypertension (PH), defined as early postoperative mean pulmonary artery pressure (mPAP) of ≥30 mmHg, after undergoing pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) was associated with long-term survival. All patients who underwent PEA for CTEPH at two Scandinavian centers were included in this study. Baseline characteristics and vital statuses were obtained from patient charts and national health-data registers. The patients were then categorized based on residual PH measured via right heart catheterization within 48 h after undergoing PEA. Crude and weighted flexible parametric survival models were used to estimate the association between residual PH and all-cause mortality and to quantify absolute survival differences. From 1992 to 2020, 444 patients underwent surgery. We excluded 6 patients who died on the day of surgery and 12 patients whose early postoperative pulmonary hemodynamic data was unavailable. Of the total study population (n = 426), 174 (41%) and 252 (59%) patients had an early postoperative mPAP <30 and ≥30 mmHg, respectively. After weighting, there was a significant association between residual PH and all-cause mortality (hazard ratio: 2.49; 95% confidence interval [CI]: 1.60–3.87), and the absolute survival difference between the groups at 10 and 20 years was –22% (95% CI: –32% to –12%) and–32% (95% CI: –47% to –18%), respectively. A strong and clinically relevant association of residual PH with long-term survival after PEA for CTEPH was found. After accounting for differences in baseline characteristics, the absolute survival difference at long-term follow-up was clinically meaningful and imply careful surveillance to improve clinical outcomes in these patients. Early postoperative right heart catheter measurements of mPAP seem to be helpful for prognostication following PEA for CTEPH.",
keywords = "epidemiology, long-term prognosis, surgery",
author = "Janica Kallonen and Kasper Korsholm and Fredrik Bredin and Matthias Corbascio and {J{\o}nsson Andersen}, Mads and Ilkj{\ae}r, {Lars Bo} and S{\o}ren Mellemkj{\ae}r and Ulrik Sartipy",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.",
year = "2022",
doi = "10.1002/pul2.12093",
language = "English",
volume = "12",
journal = "Pulmonary Circulation",
issn = "2045-8932",
publisher = "University of Chicago Press",
number = "2",

}

RIS

TY - JOUR

T1 - Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

AU - Kallonen, Janica

AU - Korsholm, Kasper

AU - Bredin, Fredrik

AU - Corbascio, Matthias

AU - Jønsson Andersen, Mads

AU - Ilkjær, Lars Bo

AU - Mellemkjær, Søren

AU - Sartipy, Ulrik

N1 - Publisher Copyright: © 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.

PY - 2022

Y1 - 2022

N2 - This study investigated whether residual pulmonary hypertension (PH), defined as early postoperative mean pulmonary artery pressure (mPAP) of ≥30 mmHg, after undergoing pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) was associated with long-term survival. All patients who underwent PEA for CTEPH at two Scandinavian centers were included in this study. Baseline characteristics and vital statuses were obtained from patient charts and national health-data registers. The patients were then categorized based on residual PH measured via right heart catheterization within 48 h after undergoing PEA. Crude and weighted flexible parametric survival models were used to estimate the association between residual PH and all-cause mortality and to quantify absolute survival differences. From 1992 to 2020, 444 patients underwent surgery. We excluded 6 patients who died on the day of surgery and 12 patients whose early postoperative pulmonary hemodynamic data was unavailable. Of the total study population (n = 426), 174 (41%) and 252 (59%) patients had an early postoperative mPAP <30 and ≥30 mmHg, respectively. After weighting, there was a significant association between residual PH and all-cause mortality (hazard ratio: 2.49; 95% confidence interval [CI]: 1.60–3.87), and the absolute survival difference between the groups at 10 and 20 years was –22% (95% CI: –32% to –12%) and–32% (95% CI: –47% to –18%), respectively. A strong and clinically relevant association of residual PH with long-term survival after PEA for CTEPH was found. After accounting for differences in baseline characteristics, the absolute survival difference at long-term follow-up was clinically meaningful and imply careful surveillance to improve clinical outcomes in these patients. Early postoperative right heart catheter measurements of mPAP seem to be helpful for prognostication following PEA for CTEPH.

AB - This study investigated whether residual pulmonary hypertension (PH), defined as early postoperative mean pulmonary artery pressure (mPAP) of ≥30 mmHg, after undergoing pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) was associated with long-term survival. All patients who underwent PEA for CTEPH at two Scandinavian centers were included in this study. Baseline characteristics and vital statuses were obtained from patient charts and national health-data registers. The patients were then categorized based on residual PH measured via right heart catheterization within 48 h after undergoing PEA. Crude and weighted flexible parametric survival models were used to estimate the association between residual PH and all-cause mortality and to quantify absolute survival differences. From 1992 to 2020, 444 patients underwent surgery. We excluded 6 patients who died on the day of surgery and 12 patients whose early postoperative pulmonary hemodynamic data was unavailable. Of the total study population (n = 426), 174 (41%) and 252 (59%) patients had an early postoperative mPAP <30 and ≥30 mmHg, respectively. After weighting, there was a significant association between residual PH and all-cause mortality (hazard ratio: 2.49; 95% confidence interval [CI]: 1.60–3.87), and the absolute survival difference between the groups at 10 and 20 years was –22% (95% CI: –32% to –12%) and–32% (95% CI: –47% to –18%), respectively. A strong and clinically relevant association of residual PH with long-term survival after PEA for CTEPH was found. After accounting for differences in baseline characteristics, the absolute survival difference at long-term follow-up was clinically meaningful and imply careful surveillance to improve clinical outcomes in these patients. Early postoperative right heart catheter measurements of mPAP seem to be helpful for prognostication following PEA for CTEPH.

KW - epidemiology

KW - long-term prognosis

KW - surgery

U2 - 10.1002/pul2.12093

DO - 10.1002/pul2.12093

M3 - Journal article

C2 - 35795490

AN - SCOPUS:85132940396

VL - 12

JO - Pulmonary Circulation

JF - Pulmonary Circulation

SN - 2045-8932

IS - 2

M1 - e12093

ER -

ID: 344908995